Literature DB >> 8041741

Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice.

S D Hursting1, S N Perkins, J M Phang.   

Abstract

Transgenic mice with both alleles of the p53 tumor suppressor gene (frequently mutated in human tumors) knocked out by gene targeting provide a potentially useful tumorigenesis model because these mice rapidly develop spontaneous tumors. To determine whether tumorigenesis in p53-knockout mice is sensitive to experimental manipulation, tumor development in response to calorie restriction (CR; a potent inhibitor of rodent tumors) was evaluated. Tumor development was monitored for 48 weeks in male nullizygous p53-knockout and wild-type littermate mice (28-30 per treatment group) fed ad libitum (AL) or restricted to 60% of AL carbohydrate calorie intake. CR:p53-knockout mice (median survival = 25 weeks) experienced a delay in tumor onset and subsequent mortality (P = 0.0002) relative to AL:p53-knockout mice (median survival = 16 weeks). Tumor development and mortality in wild-type littermates on either diet treatment were < 4% through 48 weeks. Cell cycle analyses were performed on splenocytes from p53-knockout mice and wild-type littermates after 4 weeks of AL feeding or CR (5 per group). The percentage of splenocytes in S phase of the cell cycle was 3-fold higher for p53-knockout mice than wild-type mice (P < 0.001), and CR reduced the percentage of S-phase splenocytes in both p53-knockout and wild-type mice (P = 0.012). These data demonstrate that tumor development in p53-knockout mice genetically predisposed to tumors can be delayed by CR (possibly via cell cycle modulation) and suggest that these mice provide a very useful model of spontaneous tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041741      PMCID: PMC44333          DOI: 10.1073/pnas.91.15.7036

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Trend and homogeneity analyses of proportions and life table data.

Authors:  D G Thomas; N Breslow; J J Gart
Journal:  Comput Biomed Res       Date:  1977-08

2.  Calorie restriction and cellular proliferation in various tissues of the female Swiss Webster mouse.

Authors:  E Lok; F W Scott; R Mongeau; E A Nera; S Malcolm; D B Clayson
Journal:  Cancer Lett       Date:  1990-05-15       Impact factor: 8.679

3.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

4.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

Authors:  S Srivastava; Z Q Zou; K Pirollo; W Blattner; E H Chang
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  Mitotic activity in mice is suppressed by energy restriction-induced torpor.

Authors:  A Koizumi; M Tsukada; Y Wada; H Masuda; R Weindruch
Journal:  J Nutr       Date:  1992-07       Impact factor: 4.798

7.  Food restriction retards age-related histological changes in rat small intestine.

Authors:  T D Heller; P R Holt; A Richardson
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

Review 8.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

9.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.

Authors:  E Yonish-Rouach; D Resnitzky; J Lotem; L Sachs; A Kimchi; M Oren
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

10.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

Authors:  W S el-Deiry; J W Harper; P M O'Connor; V E Velculescu; C E Canman; J Jackman; J A Pietenpol; M Burrell; D E Hill; Y Wang
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

View more
  45 in total

1.  Reduced energy intake: the secret to a long and healthy life?

Authors:  Bronwen Martin; Erin Golden; Josephine M Egan; Mark P Mattson; Stuart Maudsley
Journal:  IBS J Sci       Date:  2007-09

Review 2.  Protective effects of short-term dietary restriction in surgical stress and chemotherapy.

Authors:  Sebastian Brandhorst; Eylul Harputlugil; James R Mitchell; Valter D Longo
Journal:  Ageing Res Rev       Date:  2017-02-20       Impact factor: 10.895

Review 3.  Aging and cancer: can mTOR inhibitors kill two birds with one drug?

Authors:  Zelton Dave Sharp; Arlan Richardson
Journal:  Target Oncol       Date:  2011-03-11       Impact factor: 4.493

Review 4.  Fasting and fasting-mimicking diets for chemotherapy augmentation.

Authors:  Sebastian Brandhorst
Journal:  Geroscience       Date:  2021-01-07       Impact factor: 7.713

Review 5.  Rapalogs in cancer prevention: anti-aging or anticancer?

Authors:  Mikhail V Blagosklonny
Journal:  Cancer Biol Ther       Date:  2012-11-14       Impact factor: 4.742

Review 6.  NRF2, cancer and calorie restriction.

Authors:  A Martín-Montalvo; J M Villalba; P Navas; R de Cabo
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

Review 7.  Development and Significance of Mouse Models in Lymphoma Research.

Authors:  Jordan N Noble; Anjali Mishra
Journal:  Curr Hematol Malig Rep       Date:  2019-04       Impact factor: 3.952

8.  Limited role of Sirt1 in cancer protection by dietary restriction.

Authors:  Daniel Herranz; Gema Iglesias; Maribel Muñoz-Martín; Manuel Serrano
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

9.  Effects of calorie restriction and ω-3 dietary fat on aging in short-and long-lived rodents.

Authors:  D A Troyer; J T Venkatraman; G Fernandes
Journal:  Age (Omaha)       Date:  1998-10

10.  The new biology of ageing.

Authors:  Linda Partridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-01-12       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.